These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7037046)

  • 1. Addition of pindolol to routine medical therapy: a clinical trial.
    Smith RJ; Blamires T; Nagasubramanian S; Watkins R; Poinoosawmy D
    Br J Ophthalmol; 1982 Feb; 66(2):102-8. PubMed ID: 7037046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical suitability of pindolol eyedrops in the treatment of chronic open-angle glaucoma].
    Dausch D; Görlich W; Honegger H
    Klin Monbl Augenheilkd; 1984 Jun; 184(6):539-42. PubMed ID: 6384637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pindolol on intraocular pressure in glaucoma: pilot study and a randomised comparison with timolol.
    Andréasson S; Jensen KM
    Br J Ophthalmol; 1983 Apr; 67(4):228-30. PubMed ID: 6338906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is pindolol suitable for the therapy of glaucoma? Evaluation of the dose-effect of various concentrations of pindolol eyedrops].
    Dausch D; Görlich W; Honegger H
    Klin Monbl Augenheilkd; 1984 Jun; 184(6):536-8. PubMed ID: 6384636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pindolol eye drops (Glauco-Visken) - half year's results in glaucoma therapy].
    Merté HJ; Stryz JR; Mertz M
    Klin Monbl Augenheilkd; 1984 Mar; 184(3):227-32. PubMed ID: 6374263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pindolol and timolol treatment on the visual fields of glaucoma patients.
    Flammer J; Robert Y; Gloor B
    J Ocul Pharmacol; 1986; 2(4):305-11. PubMed ID: 3503114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of 1-year use of local pindolol in open-angle glaucoma].
    Stryz JR; Merté HJ
    Klin Monbl Augenheilkd; 1985 Jan; 186(1):43-5. PubMed ID: 3974160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pindolol eye drops - a new beta receptor blockader in the therapy of open-angle glaucoma. Comparative study of 4 weeks' duration].
    Heckenhahn K; Levermann H; Tauchert A; Wolf H
    Med Welt; 1983 Jun; 34(23):676-8. PubMed ID: 6877080
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of pindolol on intraocular pressure.
    Bonomi I; Steindler P
    Br J Ophthalmol; 1975 Jun; 59(6):301-3. PubMed ID: 1100097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of various beta blockers on intraocular pressure and ventilation].
    Bleckmann H; Dorow P
    Fortschr Ophthalmol; 1986; 83(5):567-9. PubMed ID: 2878863
    [No Abstract]   [Full Text] [Related]  

  • 11. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial.
    Garway-Heath DF; Crabb DP; Bunce C; Lascaratos G; Amalfitano F; Anand N; Azuara-Blanco A; Bourne RR; Broadway DC; Cunliffe IA; Diamond JP; Fraser SG; Ho TA; Martin KR; McNaught AI; Negi A; Patel K; Russell RA; Shah A; Spry PG; Suzuki K; White ET; Wormald RP; Xing W; Zeyen TG
    Lancet; 2015 Apr; 385(9975):1295-304. PubMed ID: 25533656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labetalol and pindolol in the treatment of hypertension: a comparative study.
    Romo M; Halttunen P; Saarinen P; Sarna S
    Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product].
    Yamamoto T;
    Nippon Ganka Gakkai Zasshi; 2007 Jun; 111(6):463-72. PubMed ID: 17601060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ocular hypotensive effect of low doses of timolol].
    Erichev VP; Salminen L; Maĭchuk IuF
    Vestn Oftalmol; 1987; 103(6):15-7. PubMed ID: 3328383
    [No Abstract]   [Full Text] [Related]  

  • 15. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure.
    Koseki N; Araie M; Tomidokoro A; Nagahara M; Hasegawa T; Tamaki Y; Yamamoto S
    Ophthalmology; 2008 Nov; 115(11):2049-57. PubMed ID: 18672290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular and cardiovascular effects of local and systemic pindolol.
    Smith SE; Smith SA; Reynolds F; Whitmarsh VB
    Br J Ophthalmol; 1979 Jan; 63(1):63-6. PubMed ID: 367433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, double-masked, placebo-controlled trial: baseline characteristics.
    Lascaratos G; Garway-Heath DF; Burton R; Bunce C; Xing W; Crabb DP; Russell RA; Shah A;
    Ophthalmology; 2013 Dec; 120(12):2540-2545. PubMed ID: 24126032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norepinephrine dipivalylate dose-response in ocular hypertensive subjects.
    Stewart RH; Kimbrough RL; Martin PA; Ward RL; Smith JP
    Ann Ophthalmol; 1981 Nov; 13(11):1279-83. PubMed ID: 7034617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta-blockader, pindolol, in the therapy of angina pectoris; a report on a multicentric controlled study].
    Lang E; Fitscha P; Schiess W
    Wien Med Wochenschr; 1979 Sep; 129(17):484-8. PubMed ID: 120078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma.
    Nishimoto JH; Chang FW; Tang IH; Kolin T
    J Am Optom Assoc; 1999 Apr; 70(4):233-9. PubMed ID: 10457699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.